It appears that a 6 month review is not guaranteed
Post# of 144499
per the May 11th PR
"the Company plans to request a priority review for the BLA. A priority review designation, if granted, means the FDA’s goal is to take action on the application within six months of receipt (compared with 10 months under standard review)."
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)